The latest version of Abbott's FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible people with diabetes in the UK. Abbott's wearable FreeStyle Libre 3 device – which is ...

The FDA has updated some information about the December recall of certain Abbott FreeStyle Libre 3 and 3 Plus glucose sensors. In December 2025, FDA posted an early alert that Abbott Diabetes Care was ...

Feb. 4 (UPI) --Officials for Abbott Diabetes Care have recalled some of the company's FreeStyle Libre 3 and FreeStyle Libre 3 Plus continuous glucose monitor sensors for people with diabetes. The Food ...

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Abbott Laboratories (NYSE:ABT) received an FDA warning ...

Abbott has been hit with a slew of complaints from the FDA in a warning letter related to its continuous glucose monitor (CGM) franchise, FreeStyle Libre. Last October, an agency inspection of ...

Check out the Closed Beta Test Trailer for Freestyle Football 2, a 5v5 football (soccer) action game developed by WOORE. Players will use fast reflexes and quick strategic movements to gain the upper ...

The National Testing Agency has released the JEE Main 2026 Session 2 application form. Eligible students can fill out on the official website, jeemain.nta.nic.in. The online registration process has ...

The National Testing Agency (NTA) will open the registration for JEE Main 2026 Session 2 from February 1, 2026. Candidates who wish to appear for the April session can apply online once the portal ...

Feb 4 (Reuters) - Medical device maker Abbott Laboratories (ABT.N), opens new tab has reported 860 serious injuries linked to the recall of some of its glucose monitoring sensors, the U.S. Food and ...

The Gujarat Public Service Commission (GPSC) has released the official notification for its 2026 recruitment drive inviting applications for 279 Class‑1 and Class‑2 government posts across multiple ...

The integrated system is now being used in real-world care settings and is widely available for people with type 1 diabetesMANCHESTER, N.H. and GERMANTOWN, Md., Feb. 19, 2026 (GLOBE NEWSWIRE) -- ...